ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 102

Positive Affect and Emotion Regulation Protect Juvenile-Onset Lupus and Dermatomyositis Patients from Emotional Distress: Longitudinal Analysis of Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study Parent-Reported Resiliency Data

Kaveh Ardalan1, Wenshan Yu2, Hwanhee Hong2, Angel Davalos2, Bryce Reeve2, Christoph Hornik2, M. Anthony Moody2, Donald Lloyd-Jones3, Rebecca Sadun1, Jeffrey Dvergsten2, Lauren Covert2, Ann Reed2, Eveline Wu4, Laura Cannon5, Leonard Kovalick6, Caitlan Pinotti6, Aliese Sarkissian6, Audrey Ward7, Simisola Gbadegesin8, Mark Connelly9 and Laura Schanberg10, 1Duke University School of Medicine, Durham, NC, 2Duke University School of Medicine, 3Boston University Chobanian & Avedisian School of Medicine, 4UNC Chapel Hill, Chapel Hill, NC, 5University of North Carolina at Chapel Hill, Chapel Hill, NC, 6University of North Carolina School of Medicine, 7Children's National Hospital, 8Wake Forest University School of Medicine, 9Children’s Mercy Kansas City/University of Missouri-Kansas City School of Medicine, Kansas City, MO, 10Duke University Medical Center, DURHAM, NC

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Posters: Clinical and Therapeutic Aspects II

Session Time: 5:00PM-6:00PM

Background/Purpose: Patients with juvenile lupus and dermatomyositis (JSLE/JDM) often experience persistent emotional distress and early loss of cardiovascular health (CVH)—the sum of protective factors that reduce cardiovascular disease risk. We previously found that elevated emotional distress trajectories were associated with worse CVH trajectories, especially for diet and physical activity. To inform future intervention targets, we examined parent-reported resiliency factors hypothesized to associate with lower emotional distress and better diet/physical activity.

Methods: The LEADS-CV cohort has been described previously (https://duke.is/y/cx66). We included 58 participants with complete data. Emotional distress was assessed using parent-proxy PROMIS Pediatric Psychological Stress Experiences, Depressive Symptoms, and Anxiety measures (PROMIS-Stress/-Depr/-Anx). Resiliency factors were evaluated for both patients (parent-proxy PROMIS Positive Affect; Emotion Dysregulation Inventory Reactivity & Dysphoria subscales [EDI-R/-D]) and parents (self-reported PROMIS Self Efficacy & Emotional Support). Parent-proxy measures of diet quality (FLASHE screener) and physical activity (PROMIS Physical Activity) were administered. Growth mixture models (GMM) were used to identify latent resiliency trajectories, and linear mixed-effects models (LMM) examined associations among resiliency factors, emotional distress, and diet/physical activity.

Results: GMMs identified good, fair, and poor latent trajectories for parent-proxy PROMIS Positive Affect and EDI-R/EDI-D, and good and poor trajectories for parent self-report PROMIS Self Efficacy & Emotional Support (Figure 1). Poor resiliency trajectories were common (17-53%) and associated with higher baseline emotional distress. LMMs showed consistent associations of PROMIS Positive Affect, EDI-R, and EDI-D with all emotional distress measures (β range |0.34–0.74| in expected directions, Table 1). Parent-reported PROMIS Emotional Support was inversely associated with parent-proxy PROMIS-Stress and PROMIS-Depr (β = -0.21 & -0.22 respectively), and parent-reported PROMIS Self Efficacy was inversely associated with PROMIS-Depr and PROMIS-Anx (both β = -0.18) (Table 1). Higher PROMIS-Depr scores were uniquely linked to worse diet quality (β range -0.56 to -0.77, Table 2), while no other consistent relationships emerged among emotional distress, resiliency factors, diet quality, or physical activity (not shown).

Conclusion: Enhancing positive affect and emotion regulation in patients and strengthening emotional support and self-efficacy among caregivers may mitigate emotional distress in patients with JSLE/JDM. Depressive symptoms may uniquely predispose JSLE/JDM patients to worse diet quality and warrant attention in CVH behavior change interventions. Further research incorporating novel assessment tools (e.g., wearable devices) and intensive study designs (e.g., ecological momentary assessment) is needed to further elucidate the dynamic associations between emotional distress and CVH behaviors.

Figure 1: Resiliency Factor Latent TrajectoriesSupporting image 1

Table 1: Linear Mixed-Effects Models (LMM): Associations of Resiliency Factors & Emotional Distress MeasuresSupporting image 2

Table 2: Linear Mixed-Effects Models Reveal Unique Association of Higher Depressive Symptoms with Worse Diet QualitySupporting image 3


Disclosures: K. Ardalan: Cabaletta Bio, 1, 2, 5, Cartesian Therapeutics, 2, SingHealth, 6, 11; W. Yu: None; H. Hong: None; A. Davalos: None; B. Reeve: Daiichi Sankyo, 2, Dartmouth University, 2, Johns Hopkins University, 2, University of North Carolina at Chapel Hill, 2, Vertex Pharmaceuticals, 2; C. Hornik: Cytokinetics, 1, Emmes Corporation, 12, DSMB, Tellus, 2; M. Moody: Grid Therapeutics, LLC., 8; D. Lloyd-Jones: None; R. Sadun: None; J. Dvergsten: Rare Disease Research, 2; L. Covert: None; A. Reed: None; E. Wu: Pharming Healthcare, Inc, 2, 6, Sumitomo Pharma America, 1; L. Cannon: None; L. Kovalick: None; C. Pinotti: None; A. Sarkissian: None; A. Ward: None; S. Gbadegesin: None; M. Connelly: None; L. Schanberg: AbbVie, 5, Amgen, 5, Bristol-Myers Squibb(BMS), 5, Frenesius Kabi, 5, Pfizer, 5, Sanofi, 12, DSMB.

To cite this abstract in AMA style:

Ardalan K, Yu W, Hong H, Davalos A, Reeve B, Hornik C, Moody M, Lloyd-Jones D, Sadun R, Dvergsten J, Covert L, Reed A, Wu E, Cannon L, Kovalick L, Pinotti C, Sarkissian A, Ward A, Gbadegesin S, Connelly M, Schanberg L. Positive Affect and Emotion Regulation Protect Juvenile-Onset Lupus and Dermatomyositis Patients from Emotional Distress: Longitudinal Analysis of Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study Parent-Reported Resiliency Data [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/positive-affect-and-emotion-regulation-protect-juvenile-onset-lupus-and-dermatomyositis-patients-from-emotional-distress-longitudinal-analysis-of-lupus-erythematosus-and-dermatomyositis-stress-and-ca/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/positive-affect-and-emotion-regulation-protect-juvenile-onset-lupus-and-dermatomyositis-patients-from-emotional-distress-longitudinal-analysis-of-lupus-erythematosus-and-dermatomyositis-stress-and-ca/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology